Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Полное описание

Библиографические подробности
Главные авторы:	Sebastian, S, Lambe, T
Формат:	Journal article
Опубликовано:	MDPI 2018

Схожие документы

Clinical Advances in Viral-Vectored Influenza Vaccines
по: Sarah Sebastian, и др.
Опубликовано: (2018-05-01)

Viral vector vaccines
по: McCann, N, и др.
Опубликовано: (2022)

Clinical development of viral vectored vaccines against MERS-COV
по: Ewer, K, и др.
Опубликовано: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
по: D. A. Mezhenskaia, и др.
Опубликовано: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
по: Bissett, C, и др.
Опубликовано: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
по: Ewer (nee Russell), K, и др.
Опубликовано: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
по: Cameron Bissett, и др.
Опубликовано: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
по: Arunkumar, G, и др.
Опубликовано: (2019)

Research advances in replication-deficient viral vector vaccines
по: Junna Wang, и др.
Опубликовано: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
по: McMahon, M, и др.
Опубликовано: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
по: Antrobus, R
Опубликовано: (2014)

Safety of the novel influenza viral vector Brucella abortus vaccine in pregnant heifers
по: Kaissar Tabynov, и др.
Опубликовано: (2016-01-01)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
по: Tully, C, и др.
Опубликовано: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
по: Tully, C
Опубликовано: (2015)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
по: Meagan McMahon, и др.
Опубликовано: (2019-08-01)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
по: Mullin, J, и др.
Опубликовано: (2014)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
по: Marta Ulaszewska, и др.
Опубликовано: (2023-01-01)

Development of viral vectors for passive immunisation against influenza
по: Tan, TK
Опубликовано: (2017)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
по: Irina Isakova-Sivak, и др.
Опубликовано: (2022-07-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
по: Antrobus, R, и др.
Опубликовано: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
по: Antrobus, R, и др.
Опубликовано: (2014)

Adenoviral vectors as novel vaccines for influenza.
по: Coughlan, L, и др.
Опубликовано: (2015)

Virus-Vectored Influenza Virus Vaccines
по: Ralph A. Tripp, и др.
Опубликовано: (2014-08-01)

Viral vectors for malaria vaccine development.
по: Li, S, и др.
Опубликовано: (2007)

The use of viral vectors in vaccine development
по: Tatianna Travieso, и др.
Опубликовано: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
по: Kenneth Lundstrom
Опубликовано: (2016-11-01)

Developments in Viral Vector-Based Vaccines
по: Takehiro Ura, и др.
Опубликовано: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
по: Ewer (nee Russell), K, и др.
Опубликовано: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
по: Kapulu, MC
Опубликовано: (2014)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
по: Katie Ewer, и др.
Опубликовано: (2017-12-01)

Recombinant influenza A viruses as vaccine vectors
по: Thomas Gerlach, и др.
Опубликовано: (2019-04-01)

Viral vectors as vaccine platforms: Deployment in sight
по: Rollier, C, и др.
Опубликовано: (2011)

Novel viral vector vaccines for tropical infections
по: Rampling, T
Опубликовано: (2017)

Viral vectors as vaccine platforms: deployment in sight.
по: Rollier, C, и др.
Опубликовано: (2011)

Viral Vectors for COVID-19 Vaccine Development
по: Kenneth Lundstrom
Опубликовано: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
по: Luis Jiménez-Cabello, и др.
Опубликовано: (2020-12-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
по: Jianfeng Zhang
Опубликовано: (2012-11-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
по: Sushmita Kumari, и др.
Опубликовано: (2022-08-01)

Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies
по: Sholpan Ryskeldinova, и др.
Опубликовано: (2021-07-01)

Advances in Adjuvanted Influenza Vaccines
по: Shintaro Shichinohe, и др.
Опубликовано: (2023-08-01)